Publications

• Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
  Geller, A. C., Mayer, J. E., Sober, A. J., Miller, D. R., Argenziano, G., & Swetter, S. M. (2016). Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers. JAMA dermatology, 152(4), 413-418.
• Molecular Profiling in Cutaneous Melanoma.
  Ji, A. L., Bichakjian, C. K., & Swetter, S. M. (2016). Molecular Profiling in Cutaneous Melanoma. Journal of the National Comprehensive Cancer Network , 14(4), 475-480.
• Loss of primary cilia correlates withcytologic severity in dysplastic melanocytic nevi
  Lang, U. E., Cheung, C., Vladar, E. K., Swetter, S. M., & Kim, J. (2016). Loss of primary cilia correlates withcytologic severity in dysplastic melanocytic nevi. JOURNAL OF CUTANEOUS PATHOLOGY, 43(2), 113-119.
• Tumor Ulceration does not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults. Keegan, T. H., Swetter, S. M., Tao, L., Sunwoo, J. B., & Clarke, C. A. (2015). Tumor Ulceration does not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults. The Journal of investigative dermatology.
  
• Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type Swetter, S. M., Chen, F. W., Kim, D. D., & Egbert, B. M. (2015). Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(6), 1047-1053.
  
• Focus on early detection to reduce melanoma deaths. Geller, A. C., Swetter, S. M., & Weinstock, M. A. (2015). Focus on early detection to reduce melanoma deaths. journal of investigative dermatology, 135(4), 947-949.
  
• The Impact of Indoor Tanning Legislation: Newspaper Coverage of the Risks of Indoor Tanning Before and After the California Indoor Tanning Ban for Minors Mayer, J. E., Swetter, S. M., Guild, S., & Geller, A. C. (2015). The Impact of Indoor Tanning Legislation: Newspaper Coverage of the Risks of Indoor Tanning Before and After the California Indoor Tanning Ban for Minors. JOURNAL OF CANCER EDUCATION, 30(1), 124-129.
  
• Addressing the Knowledge Gap in Clinical Recommendations for Management and Complete Excision of Clinically Atypical Nevi/Dysplastic Nevi Pigmented Lesion Subcommittee Consensus Statement Kim, C. C., Swetter, S. M., Curiel-Lewandrowski, C., Grichnik, Jm., Grossman, D., & Chen, S. C. (2015). Addressing the Knowledge Gap in Clinical Recommendations for Management and Complete Excision of Clinically Atypical Nevi/Dysplastic Nevi Pigmented Lesion Subcommittee Consensus Statement. JAMA DERMATOLOGY, 151(2), 212-218.
  
• Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma. Cloyd, J. M., Wapnir, I. L., Read, B. M., Swetter, S., & Greco, R. S. (2014). Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma. Journal of surgical oncology, 110(7), 888-892.
  
• Indocyanine Green and Fluorescence Lymphangiography for Sentinel Lymph Node Identification in Cutaneous Melanoma Cloyd, J. M., Wapnir, I. L., Read, B. M., Swetter, S., & Greco, R. S. (2014). Indocyanine Green and Fluorescence Lymphangiography for Sentinel Lymph Node Identification in Cutaneous Melanoma. JOURNAL OF SURGICAL ONCOLOGY, 110(7), 888-892.
  
• Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative Wysong, A., Ally, M. S., Gamba, C. S., Desai, M., Swetter, S. M., & Tang, J. Y. (2014). Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative. PREVENTIVE MEDICINE, 69, 8-12.
  
• Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative. Wysong, A., Ally, M. S., Gamba, C. S., Desai, M., Swetter, S. M., & Tang, J. Y. (2014). Non-melanoma skin cancer and NSAID use in women with a history of skin cancer in the Women's Health Initiative. Preventive medicine, 69, 8-12.
  
• Perspective: catch melanoma early. Swetter, S. M., & Geller, A. C. (2014). Perspective: catch melanoma early. Nature, 515(7527), S117-?.
  
• Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy. Chen, F. W., Tseng, D., Reddy, S., Daud, A. I., & Swetter, S. M. (2014). Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy. JAMA dermatology, 150(11), 1209-1212.
  
• Involution of Eruptive Melanocytic Nevi on Combination BRAF and MEK Inhibitor Therapy Chen, F. W., Tseng, D., Reddy, S., Daud, A. I., & Swetter, S. M. (2014). Involution of Eruptive Melanocytic Nevi on Combination BRAF and MEK Inhibitor Therapy. JAMA DERMATOLOGY, 150(11), 1209-1212.
  
• Tumor Volume: An Adjunct Prognostic Factor in Cutaneous Melanoma Walton, R. G., Kim, J., Velasco, C., & Swetter, S. M. (2014). Tumor Volume: An Adjunct Prognostic Factor in Cutaneous Melanoma. CUTIS, 94(5), 226-230.
  
• Health behaviors and needs of melanoma survivors Palesh, O., Aldridge-Gerry, A., Bugos, K., Pickham, D., Chen, J. J., & Swetter, S. M. (2014). Health behaviors and needs of melanoma survivors. SUPPORTIVE CARE IN CANCER, 22(11), 2973-2980.
  
• Health behaviors and needs of melanoma survivors. Palesh, O., Aldridge-Gerry, A., Bugos, K., Pickham, D., Chen, J. J., & Swetter, S. M. (2014). Health behaviors and needs of melanoma survivors. Supportive care in cancer , 22(11), 2973-2980.
  
• Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part II. Screening, education, and future directions. Mayer, J. E., Swetter, S. M., Fu, T., & Geller, A. C. (2014). Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part II. Screening, education, and future directions. Journal of the American Academy of Dermatology, 71(4), 611 e1-611 e10.
  
• Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology Mayer, J. E., Swetter, S. M., Fu, T., & Geller, A. C. (2014). Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 71(4).
  
• Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions Part II. Screening, education, and future directions Mayer, J. E., Swetter, S. M., Fu, T., & Geller, A. C. (2014). Screening, early detection, education, and trends for melanoma: Current status (2007-2013) and future directions Part II. Screening, education, and future directions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 71(4).
  
• Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population Talaganis, J. A., Biello, K., Plaka, M., Polydorou, D., Papadopoulos, O., & Stratigos, A. J. (2014). Demographic, behavioural and physician-related determinants of early melanoma detection in a low-incidence population. BRITISH JOURNAL OF DERMATOLOGY, 171(4), 832-838.
  
• Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology. Mayer, J. E., Swetter, S. M., Fu, T., & Geller, A. C. (2014). Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I. Epidemiology, high-risk groups, clinical strategies, and diagnostic technology. Journal of the American Academy of Dermatology, 71(4), 599 e1-599 e12.
  
• Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients Demarchis, E. H., Swetter, S. M., Jennings, C. D., & Kim, J. (2014). Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients. PEDIATRIC DERMATOLOGY, 31(5), 561-569.
  
• Acquired blue nevi in older individuals: retrospective case series from a Veterans Affairs population, 1991 to 2013. Cabral, E. S., Chen, F. W., Egbert, B. M., & Swetter, S. M. (2014). Acquired blue nevi in older individuals: retrospective case series from a Veterans Affairs population, 1991 to 2013. JAMA dermatology, 150(8), 873-876.
  
• Acquired Blue Nevi in Older Individuals Retrospective Case Series From a Veterans Affairs Population, 1991 to 2013 Cabral, E. S., Chen, F. W., Egbert, B. M., & Swetter, S. M. (2014). Acquired Blue Nevi in Older Individuals Retrospective Case Series From a Veterans Affairs Population, 1991 to 2013. JAMA DERMATOLOGY, 150(8), 873-876.
  
• Measuring the severity of topical 5-Fluorouracil toxicity. Korgavkar, K., Firoz, E. F., Xiong, M., Lew, R., Marcolivio, K., & Weinstock, M. A. (2014). Measuring the severity of topical 5-Fluorouracil toxicity. Journal of cutaneous medicine and surgery, 18(4), 229-235.
  
• Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines Coit, D. G., Thompson, J. A., Andtbacka, R., Anker, C. J., Bichakjian, C. K., & Ho, M. (2014). Melanoma, Version 4.2014 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 12(5), 621-629.
  
• Dermatomyositis associated with capecitabine in the setting of malignancy Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(2), E47-E48.
  
• Dermatomyositis associated with capecitabine in the setting of malignancy. Chen, F. W., Zhou, X., Egbert, B. M., Swetter, S. M., & Sarin, K. Y. (2014). Dermatomyositis associated with capecitabine in the setting of malignancy. Journal of the American Academy of Dermatology, 70(2), e47-8.
  
• Reliability of quantification measures of actinic keratosis Chen, S. C., Hill, N. D., Veledar, E., Swetter, S. M., & Weinstock, M. A. (2013). Reliability of quantification measures of actinic keratosis. BRITISH JOURNAL OF DERMATOLOGY, 169(6), 1219-1222.
  
• Pediatric Melanoma: Analysis of an International Registry Averbook, B. J., Lee, S. J., Delman, K. A., Gow, K. W., Zager, J. S., & Kirkwood, J. M. (2013). Pediatric Melanoma: Analysis of an International Registry. CANCER, 119(22), 4012-4019.
  
• Role of aspirin and non-aspirin NSAIDs in preventing melanoma. Ally, M. S., Swetter, S. M., & Tang, J. Y. (2013). Role of aspirin and non-aspirin NSAIDs in preventing melanoma. Future oncology , 9(11), 1671-1674.
  
• Activating HRAS Mutation in Agminated Spitz Nevi Arising in a Nevus Spilus Sarin, K. Y., Sun, B. K., Bangs, C. D., Cherry, A., Swetter, S. M., & Khavari, P. A. (2013). Activating HRAS Mutation in Agminated Spitz Nevi Arising in a Nevus Spilus. JAMA DERMATOLOGY, 149(9), 1077-1080.
  
• Melanoma Survival Disadvantage in Young, Non-Hispanic White Males Compared With Females Gamba, C. S., Clarke, C. A., Keegan, T. Hm., Tao, L., & Swetter, S. M. (2013). Melanoma Survival Disadvantage in Young, Non-Hispanic White Males Compared With Females. JAMA DERMATOLOGY, 149(8), 912-920.
  
• Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative Gamba, C. A., Swetter, S. M., Stefanick, M. L., Kubo, J., Desai, M., & Tang, J. Y. (2013). Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women The Women's Health Initiative. CANCER, 119(8), 1562-1569.
  
• Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines Coit, D. G., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., & Ho, M. (2013). Melanoma, Version 2.2013 Featured Updates to the NCCN Guidelines. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 11(4), 395-407.
  
• A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy Hiniker, S. M., Chen, D. S., Reddy, S., Chang, D. T., Jones, J. C., & Knox, S. J. (2012). A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy. TRANSLATIONAL ONCOLOGY, 5(6), 404-407.
  
• Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma Curiel-Lewandrowski, C., Swetter, S. M., Einspahr, J. G., Hsu, C.-H., Nagle, R., & Chow, H.-H. (2012). Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma. CANCER, 118(23), 5848-5856.
  
• Screening and Prevention Measures for Melanoma: Is There a Survival Advantage? Curiel-Lewandrowski, C., Chen, S. C., & Swetter, S. M. (2012). Screening and Prevention Measures for Melanoma: Is There a Survival Advantage?. CURRENT ONCOLOGY REPORTS, 14(5), 458-467.
  
• Examining the pathways linking lower socioeconomic status and advanced melanoma Pollitt, R. A., Swetter, S. M., Johnson, T. M., Patil, P., & Geller, A. C. (2012). Examining the pathways linking lower socioeconomic status and advanced melanoma. CANCER, 118(16), 4004-4013.
  
• Behavioral determinants of successful early melanoma detection Swetter, S. M., Pollitt, R. A., Johnson, T. M., Brooks, D. R., & Geller, A. C. (2012). Behavioral determinants of successful early melanoma detection. CANCER, 118(15), 3725-3734.
  
• Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling Sondak, V. K., Swetter, S. M., & Berwick, M. A. (2012). Gender Disparities in Patients With Melanoma: Breaking the Glass Ceiling. JOURNAL OF CLINICAL ONCOLOGY, 30(18), 2177-2178.
  
• Survival Is Not the Only Valuable End Point in Melanoma Screening Curiel-Lewandrowski, C., Kim, C. C., Swetter, S. M., Chen, S. C., Halpern, A. C., & Grichnik, J. M. (2012). Survival Is Not the Only Valuable End Point in Melanoma Screening. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 132(5), 1332-1337.
  
• Reporting and registering nonmelanoma skin cancers: a compelling public health need Geller, A. C., & Swetter, S. M. (2012). Reporting and registering nonmelanoma skin cancers: a compelling public health need. BRITISH JOURNAL OF DERMATOLOGY, 166(5), 913-915.
  
• Melanoma Colt, D. G., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., & Urist, M. M. (2012). Melanoma. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 10(3), 366-400.
  
• Attitudes Toward Indoor Tanning Among Users of Sunless Tanning Products Mahoney, A., Swetter, S. M., Biello, K. B., Resnick, E. A., Feuerstein, I., & Geller, A. C. (2012). Attitudes Toward Indoor Tanning Among Users of Sunless Tanning Products. ARCHIVES OF DERMATOLOGY, 148(1), 124-126.
  
• Guidelines of care for the management of primary cutaneous melanoma Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Hood, A. F., Grichnik, J. M., & Begolka, W. S. (2011). Guidelines of care for the management of primary cutaneous melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(5), 1032-1047.
  
• Reducing mortality in individuals at high risk for advanced melanoma through education and screening Geller, A. C., Swetter, S. M., Oliveria, S., Dusza, S., & Halpern, A. C. (2011). Reducing mortality in individuals at high risk for advanced melanoma through education and screening. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 65(5), S87-S94.
  
• Increases in Melanoma Among Adolescent Girls and Young Women in California Trends by Socioeconomic Status and UV Radiation Exposure Hausauer, A. K., Swetter, S. M., Cockburn, M. G., & Clarke, C. A. (2011). Increases in Melanoma Among Adolescent Girls and Young Women in California Trends by Socioeconomic Status and UV Radiation Exposure. ARCHIVES OF DERMATOLOGY, 147(7), 783-789.
  
• Effect of oral sulindac on biomarkers of drug bioavailability and carcinogenesis in melanocytic nevi-A double-blind, randomized, placebo-controlled trial Curiel-Lewandrowski, C., Swetter, S., Einspahr, J., Hsu, C., Saboda, K., & Chow, H. (2011). Effect of oral sulindac on biomarkers of drug bioavailability and carcinogenesis in melanocytic nevi-A double-blind, randomized, placebo-controlled trial. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 131, S129-S129.
  
• The Expanding Melanoma Burden in California Hispanics Importance of Socioeconomic Distribution, Histologic Subtype, and Anatomic Location Pollitt, R. A., Clarke, C. A., Swetter, S. M., Peng, D. H., Zadnick, J., & Cockburn, M. (2011). The Expanding Melanoma Burden in California Hispanics Importance of Socioeconomic Distribution, Histologic Subtype, and Anatomic Location. CANCER, 117(1), 152-161.
  
• Interaction of Area-Level Socioeconomic Status and UV Radiation on Melanoma Occurrence in California Clarke, C. A., Moy, L. M., Swetter, S. M., Zadnick, J., & Cockburn, M. G. (2010). Interaction of Area-Level Socioeconomic Status and UV Radiation on Melanoma Occurrence in California. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 19(11), 2727-2733.
  
• Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults-The Stanford Experience 1995-2008 Berk, D. R., LaBuz, E., Dadras, S. S., Johnson, D. L., & Swetter, S. M. (2010). Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults-The Stanford Experience 1995-2008. PEDIATRIC DERMATOLOGY, 27(3), 244-254.
  
• Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study Spanogle, J. P., Clarke, C. A., Aroner, S., & Swetter, S. M. (2010). Risk of second primary malignancies following cutaneous melanoma diagnosis: A population-based study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 62(5), 757-767.
  
• Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer Rieger, K. E., Linos, E., Egbert, B. M., & Swetter, S. M. (2010). Recurrence rates associated with incompletely excised low-risk nonmelanoma skin cancer. JOURNAL OF CUTANEOUS PATHOLOGY, 37(1), 59-67.
  
• Efficacy of Skin Self-Examination Practices for Early Melanoma Detection Pollitt, R. A., Geller, A. C., Brooks, D. R., Johnson, T. M., Park, E. R., & Swetter, S. M. (2009). Efficacy of Skin Self-Examination Practices for Early Melanoma Detection. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 18(11), 3018-3023.
  
• Selection criteria for genetic assessment of patients with familial melanoma Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., & Tsao, H. (2009). Selection criteria for genetic assessment of patients with familial melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 61(4), 677-684.
  
• Increasing Burden of Melanoma in the United States Linos, E., Swetter, S. M., Cockburn, M. G., Colditz, G. A., & Clarke, C. A. (2009). Increasing Burden of Melanoma in the United States. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129(7), 1666-1674.
  
• Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis Doeden, K., Ma, Z., Narasimhan, B., Swetter, S. M., Detmar, M., & Dadras, S. S. (2009). Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis. JOURNAL OF CUTANEOUS PATHOLOGY, 36(7), 772-780.
  
• Impaired interferon signaling is a common immune defect in human cancer Critchley-Thorne, R. J., Simons, D. L., Yan, N., Miyahira, A. K., Dirbas, F. M., & Lee, P. P. (2009). Impaired interferon signaling is a common immune defect in human cancer. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(22), 9010-9015.
  
• Factors Associated With Physician Discovery of Early Melanoma in Middle-aged and Older Men Geller, A. C., Johnson, T. M., Miller, D. R., Brooks, K. R., Layton, C. J., & Swetter, S. M. (2009). Factors Associated With Physician Discovery of Early Melanoma in Middle-aged and Older Men. ARCHIVES OF DERMATOLOGY, 145(4), 409-414.
  
• Gender Differences in Melanoma Awareness and Detection Practices Between Middle-aged and Older Men With Melanoma and Their Female Spouses Swetter, S. M., Layton, C. J., Johnson, T. M., Brooks, K. R., Miller, D. R., & Geller, A. C. (2009). Gender Differences in Melanoma Awareness and Detection Practices Between Middle-aged and Older Men With Melanoma and Their Female Spouses. ARCHIVES OF DERMATOLOGY, 145(4), 488-490.
  
• Melanoma in Middle-aged and Older Men A Multi-institutional Survey Study of Factors Related to Tumor Thickness Swetter, S. M., Johnson, T. M., Miller, D. R., Layton, C. J., Brooks, K. R., & Geller, A. C. (2009). Melanoma in Middle-aged and Older Men A Multi-institutional Survey Study of Factors Related to Tumor Thickness. ARCHIVES OF DERMATOLOGY, 145(4), 397-404.
  
• Factors Related to the Presentation of Thin and Thick Nodular Melanoma From a Population-based Cancer Registry in Queensland Australia Geller, A. C., Elwood, M., Swetter, S. M., Brooks, D. R., Aitken, J., & Baade, P. D. (2009). Factors Related to the Presentation of Thin and Thick Nodular Melanoma From a Population-based Cancer Registry in Queensland Australia. CANCER, 115(6), 1318-1327.
  
• Melanoma Coit, D. G., Andtbacka, R., Bichakjian, C. K., Dilawari, R. A., Dimaio, D., & Wong, M. K. (2009). Melanoma. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 7(3), 250-275.
  
• High-molecular-weight keratin stain as a complement to Melan A stain Egbert, B. M., Rouse, R. V., & Swetter, S. M. (2008). High-molecular-weight keratin stain as a complement to Melan A stain. JOURNAL OF CUTANEOUS PATHOLOGY, 35(12), 1159-1159.
  
• Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it? Cockburn, M., Swetter, S. M., Peng, D., Keegan, T. Hm., Deapen, D., & Clarke, C. A. (2008). Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it?. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(6), 1081-1085.
  
• California medicaid Enrollment and melanoma stage at diagnosis - A population-based study Pollitt, R. A., Clarke, C. A., Shema, S. J., & Swetter, S. M. (2008). California medicaid Enrollment and melanoma stage at diagnosis - A population-based study. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 35(1), 7-13.
  
• Primary dermal melanoma Cassarino, D. S., Cabral, E. S., Kartha, R. V., & Swetter, S. M. (2008). Primary dermal melanoma. ARCHIVES OF DERMATOLOGY, 144(1), 49-56.
  
• Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions Geller, A. C., Swetter, S. M., Brooks, K., Demierre, M.-F., & Yaroch, A. L. (2007). Screening, early detection, and trends for melanoma: Current status (2000-2006) and future directions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 57(4), 555-572.
  
• Evaluation of digital dermoscopy in a pigmented lesion clinic: Clinician versus computer assessment of malignancy risk Boldrick, J. C., Layton, C. J., Nguyen, J., & Swetter, S. M. (2007). Evaluation of digital dermoscopy in a pigmented lesion clinic: Clinician versus computer assessment of malignancy risk. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 56(3), 417-421.
  
• Effect of health care delivery models on melanoma thickness and stage in a university-based referral center - An observational pilot study Swetter, S. M., Soon, S., Harrington, C. R., & Chen, S. C. (2007). Effect of health care delivery models on melanoma thickness and stage in a university-based referral center - An observational pilot study. ARCHIVES OF DERMATOLOGY, 143(1), 30-36.
  
• Crafting a melanoma educational campaign to reach middle-aged and older men Geller, J., Swetter, S. M., Leyson, J., Miller, D. R., Brooks, K., & Geller, A. C. (2006). Crafting a melanoma educational campaign to reach middle-aged and older men. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 10(6), 259-268.
  
• Facial resurfacing for nonmelanoma skin cancer prophylaxis Hantash, B. M., Stewart, D. B., Cooper, Z. A., Rehmus, W. E., Koch, R. J., & Swetter, S. M. (2006). Facial resurfacing for nonmelanoma skin cancer prophylaxis. ARCHIVES OF DERMATOLOGY, 142(8), 976-982.
  
• Slow-growing nodule on the thigh - Solitary fibrous tumor (SFT) Stewart, D. B., Egbert, B. M., Rouse, R. V., & Swetter, S. M. (2006). Slow-growing nodule on the thigh - Solitary fibrous tumor (SFT). ARCHIVES OF DERMATOLOGY, 142(7), 923-?.
  
• Use of artificial tanning products among young adults Brooks, K., Brooks, D., Dajani, Z., Swetter, S. M., Powers, E., & Geller, A. C. (2006). Use of artificial tanning products among young adults. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 54(6), 1060-1066.
  
• Sun care advertising in popular US magazines Lee, E. T., O'Riordan, D., Swetter, S. M., Demierre, M.-F., Brooks, K., & Geller, A. C. (2006). Sun care advertising in popular US magazines. AMERICAN JOURNAL OF HEALTH PROMOTION, 20(5), 349-352.
  
• A call for the development and implementation of a targeted national melanoma screening program Geller, A. C., Miller, D. R., Swetter, S. M., Demierre, M. F., & Gilchrest, B. A. (2006). A call for the development and implementation of a targeted national melanoma screening program. ARCHIVES OF DERMATOLOGY, 142(4), 504-507.
  
• Sun protection factor content and warning statements for sunless tanning products: An examination of retail outlets and the Internet Dajani, Z., Swetter, S. M., Demierre, M. F., & Geller, A. C. (2005). Sun protection factor content and warning statements for sunless tanning products: An examination of retail outlets and the Internet. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 53(5), 919-920.
  
• Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000 Swetter, S. M., Boldrick, J. C., Jung, S. Y., Egbert, B. M., & Harvell, J. D. (2005). Increasing incidence of lentigo maligna melanoma subtypes: Northern California and national trends 1990-2000. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 125(4), 685-691.
  
• Sentinel lymph node biopsy for cutaneous melanoma - The Stanford experience, 1997-2004 Berk, D. R., Johnson, D. L., Uzieblo, A., Kiernan, M., & Swetter, S. M. (2005). Sentinel lymph node biopsy for cutaneous melanoma - The Stanford experience, 1997-2004. ARCHIVES OF DERMATOLOGY, 141(8), 1016-1022.
  
• Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction Farrahi, F., Egbert, B. M., & Swetter, S. M. (2005). Histologic similarities between lentigo maligna and dysplastic nevus: importance of clinicopathologic distinction. JOURNAL OF CUTANEOUS PATHOLOGY, 32(6), 405-412.
  
• Malignant Melanoma Swetter SM. (2005). Malignant Melanoma. eMedicine Journal [serial online]. Available at: http://www.emedicine.com/derm/topic257.htm.
  
• Vaccine therapy of melanoma: an update. Demierre M-F, Swetter SM, & Sondak VK. (2005). Vaccine therapy of melanoma: an update. Current Cancer Therapy Reviews, 1.
  
• Prevention and detection of melanoma in the primary care setting. Swetter SM, & Geller AC. (2005). Prevention and detection of melanoma in the primary care setting. J Clin Outcomes Management, 12.
  
• Melanoma in the older person Swetter, S. M., Geller, A. C., & Kirkwood, J. M. (2004). Melanoma in the older person. ONCOLOGY-NEW YORK, 18(9), 1187-1196.
  
• Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome Harrington, C. R., Egbert, B. M., & Swetter, S. M. (2004). Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome. DERMATOLOGIC SURGERY, 30(5), 817-819.
  
• Diffuse verrucous, vascular nodules on the extremities and trunk Nguyen, J., Egbert, B. M., & Swetter, S. M. (2004). Diffuse verrucous, vascular nodules on the extremities and trunk. ARCHIVES OF DERMATOLOGY, 140(3), 353-?.
  
• Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions Fiorentino, D. F., Nguyen, J. C., Egbert, B. M., & Swetter, S. M. (2004). Muir-Torre syndrome: Confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 50(3), 476-478.
  
• Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis Chang, H. Y., Cooper, Z. A., Swetter, S. A., & Marinkovich, M. P. (2004). Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis. ARCHIVES OF DERMATOLOGY, 140(2), 242-244.
  
• Primary dermal melanoma - A distinct subtype of melanoma Swetter, S. M., Ecker, P. M., Johnson, D. L., & Harvell, J. D. (2004). Primary dermal melanoma - A distinct subtype of melanoma. ARCHIVES OF DERMATOLOGY, 140(1), 99-103.
  
• Challenge. Epithelioid cell histiocytoma. Stewart, D. B., Egbert, B. M., & Swetter, S. M. (2003). Challenge. Epithelioid cell histiocytoma. American Journal of dermatopathology, 25(5), 430-?.
  
• Malignant melanoma Kanzler, M. H., & Swetter, S. M. (2003). Malignant melanoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 48(5), 780-783.
  
• Current management of melanoma: Benefits of surgical staging and adjuvant therapy McMasters, K. M., & Swetter, S. M. (2003). Current management of melanoma: Benefits of surgical staging and adjuvant therapy. JOURNAL OF SURGICAL ONCOLOGY, 82(3), 209-216.
  
• Dermatological perspectives of malignant melanoma Swetter, S. M. (2003). Dermatological perspectives of malignant melanoma. SURGICAL CLINICS OF NORTH AMERICA, 83(1), 77-?.
  
• Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California Swetter, S. M., Waddell, B. L., Vazquez, B. D., & Khosravi, V. S. (2003). Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California. PREVENTIVE MEDICINE, 36(2), 164-171.
  
• Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens Swetter, S. M., Boldrick, J. C., Pierre, P., Wong, P., & Egbert, B. M. (2003). Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. JOURNAL OF CUTANEOUS PATHOLOGY, 30(2), 139-146.
  
• Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients Swetter, S. M., Carroll, L. A., Johnson, D. L., & Segall, G. A. (2002). Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patients. ANNALS OF SURGICAL ONCOLOGY, 9(7), 646-653.
  
• Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea Su, L. D., Kim, Y. H., LeBoit, P. E., Swetter, S. M., & Kohler, S. (2002). Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea. JOURNAL OF CUTANEOUS PATHOLOGY, 29(3), 135-141.
  
• Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma Dubois, R. W., Vetter, S. Ms., Atkins, M., McMasters, K., Halbert, R., & Kirkwood, J. (2001). Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma. ARCHIVES OF DERMATOLOGY, 137(9), 1217-1224.
  
• The rationale behind the 2002 AJCC Melanoma Staging Committee recommendations Swetter SM, & Ross MI. (2001). The rationale behind the 2002 AJCC Melanoma Staging Committee recommendations. The Melanoma Letter, 19(4).
  
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., & DAVIS, M. M. (1999). Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. NATURE MEDICINE, 5(6), 677-685.
  
• Hereditary ochronosis: Hyperpigmented skin overlying cartilaginous structures Garcia, S. F., Egbert, B., & Swetter, S. M. (1999). Hereditary ochronosis: Hyperpigmented skin overlying cartilaginous structures. CUTIS, 63(6), 337-338.
  
• Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma Swetter, S. M., Yaghmai, D., & Egbert, B. M. (1998). Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma. JOURNAL OF CUTANEOUS PATHOLOGY, 25(8), 420-425.
  
• Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus Swetter, S. M., HILL, E. L., Kern, E. R., Koelle, D. M., Posavad, C. M., & Safrin, S. (1998). Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. JOURNAL OF INFECTIOUS DISEASES, 177(3), 543-550.
  
• Dopamine-associated symmetric peripheral gangrene Park, J. Y., KANZLER, M., & Swetter, S. M. (1997). Dopamine-associated symmetric peripheral gangrene. ARCHIVES OF DERMATOLOGY, 133(2), 247-249.
  
• Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California Wrone, D. A., Swetter, S. M., Egbert, B. M., SMOLLER, B. R., & Khavari, P. A. (1996). Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 35(6), 907-910.
  
• Malignant melanoma from the dermatologic perspective Swetter, S. M. (1996). Malignant melanoma from the dermatologic perspective. SURGICAL CLINICS OF NORTH AMERICA, 76(6), 1287-?.
  
• Surgical margins for malignant melanoma: Another point of view Kanzler, M. H., & Swetter, S. M. (1996). Surgical margins for malignant melanoma: Another point of view. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 35(6), 1014-1015.
  
• Cutaneous myiasis following travel to Belize Swetter, S. M., Stewart, M. I., & SMOLLER, B. R. (1996). Cutaneous myiasis following travel to Belize. INTERNATIONAL JOURNAL OF DERMATOLOGY, 35(2), 118-120.
  
• SCLEREDEMA REVISITED - A POSTSTREPTOCOCCAL COMPLICATION Cron, R. Q., & Swetter, S. M. (1994). SCLEREDEMA REVISITED - A POSTSTREPTOCOCCAL COMPLICATION. CLINICAL PEDIATRICS, 33(10), 606-610.
  
• CUTANEOUS NODULES OF MYCOBACTERIUM-CHELONAE IN AN IMMUNOSUPPRESSED PATIENT WITH PREEXISTING PULMONARY COLONIZATION Swetter, S. M., Kindel, S. E., & SMOLLER, B. R. (1993). CUTANEOUS NODULES OF MYCOBACTERIUM-CHELONAE IN AN IMMUNOSUPPRESSED PATIENT WITH PREEXISTING PULMONARY COLONIZATION. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 28(2), 352-355.